Phase I Dose-Escalation and -Expansion Study of Telisotuzumab (ABT-700), an Anti–c-Met Antibody, in Patients with Advanced Solid Tumors
2020 ◽
Vol 19
(5)
◽
pp. 1210-1217
◽
John H. Strickler
◽
Patricia LoRusso
◽
Ravi Salgia
◽
Yoon-Koo Kang
◽
Chia Jui Yen
◽
...
2016 ◽
Vol 34
(3)
◽
pp. 329-337
◽
B. Milojkovic Kerklaan
◽
S. Slater
◽
M. Flynn
◽
A. Greystoke
◽
P. O. Witteveen
◽
...
2009 ◽
Vol 66
(3)
◽
pp. 441-448
◽
E. Gabriela Chiorean
◽
Srikar Malireddy
◽
Anne E. Younger
◽
David R. Jones
◽
Mary-Jane Waddell
◽
...
2012 ◽
Vol 18
(9)
◽
pp. 2658-2667
◽
Klaus Mross
◽
Annette Frost
◽
Simone Steinbild
◽
Susanne Hedbom
◽
Martin Büchert
◽
...
2006 ◽
Vol 4
(12)
◽
pp. 83
J. Sarantopoulos
◽
A.W. Tolcher
◽
A. Wong
◽
G. Goel
◽
M. Beeram
◽
...
2009 ◽
Vol 66
(4)
◽
pp. 669-680
◽
Francisco Robert
◽
Alan Sandler
◽
Joan H. Schiller
◽
Glenn Liu
◽
Karen Harper
◽
...
2014 ◽
Vol 74
(5)
◽
pp. 917-925
◽
Carlos R. Becerra
◽
Paul Conkling
◽
Nicholas Vogelzang
◽
Hilary Wu
◽
Shengyan Hong
◽
...
2014 ◽
Vol 20
(18)
◽
pp. 4747-4757
◽
Paul Haluska
◽
Michael Menefee
◽
Elizabeth R. Plimack
◽
Jonathan Rosenberg
◽
Donald Northfelt
◽
...
Todd Bauer
◽
David Hong
◽
Neeta Somaiah
◽
Charles Cai
◽
Saeheum Song
◽
...
Crystal S. Denlinger
◽
Vicki L. Keedy
◽
James M. Cleary
◽
William Kubasek
◽
Matthew Onsum
◽
...
Samuel C. Blackman
◽
Shelby D. Gainer
◽
Benjamin B. Suttle
◽
Konstantine W. Skordos
◽
Joel D. Greshock
◽
...